Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cost of Goods | N/A | N/A | N/A | 94 | 38 |
| Gross Profit | N/A | N/A | N/A | -94 | -38 |
| Operating Expenses | 19,376 | 11,656 | 6,173 | 3,561 | 1,119 |
| Operating Income | -19,376 | -11,656 | -6,173 | -3,655 | -1,157 |
| Interest Expense | 0 | 133 | 0 | 773 | 18 |
| Other Income | -203 | -188 | -2,165 | -7,733 | -63 |
| Pre-tax Income | -19,579 | -11,977 | -8,338 | -12,161 | -1,238 |
| Income Tax | 0 | 0 | 4 | N/A | N/A |
| Net Income Continuous | -19,579 | -11,977 | -8,342 | -12,161 | -1,238 |
| Net Income | $-19,579 | $-11,977 | $-8,342 | $-12,161 | $-1,238 |
| EPS Basic Total Ops | 0.17 | -0.14 | -0.24 | -0.50 | -0.04 |
| EPS Basic Continuous Ops | 0.17 | -0.14 | -0.24 | -0.50 | N/A |
| EPS Diluted Total Ops | 0.17 | -0.14 | -0.24 | -0.50 | -0.04 |
| EPS Diluted Continuous Ops | 0.17 | -0.14 | -0.24 | -0.50 | N/A |
| EBITDA(a) | $-19,565 | $-11,839 | $-8,090 | $-11,258 | $-1,220 |